Epalrestat  CAS No.: 82159-09-9 Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function. Epalrestat is used to prevent, ameliorate, and treat peripheral neuropathy (numbness, pain), vibrational paresthesia, and cardiac abnormality associated with diabetes.SPECIFICATION